|Articles|June 3, 2020
Accelerating Biopharmaceutical Tech Transfer to Address Unmet Medical Needs
Author(s)Samsung Biologics
This application note describes key activities to accelerate biopharmaceutical tech transfer to support faster development and manufacturing programs.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
